These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9805656)

  • 61. New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library.
    Fleckenstein B; Kalbacher H; Muller CP; Stoll D; Halder T; Jung G; Wiesmüller KH
    Eur J Biochem; 1996 Aug; 240(1):71-7. PubMed ID: 8797837
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates.
    Geluk A; Elferink DG; Slierendregt BL; van Meijgaarden KE; de Vries RR; Ottenhoff TH; Bontrop RE
    J Exp Med; 1993 Apr; 177(4):979-87. PubMed ID: 8459225
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
    Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
    Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.
    Lasso P; Beltrán L; Guzmán F; Rosas F; Thomas MC; López MC; González JM; Cuéllar A; Puerta CJ
    PLoS One; 2016; 11(3):e0150996. PubMed ID: 26974162
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides.
    Jurcevic S; Praud C; Coppin HL; Bertrand A; Ricard S; Thomsen M; Lakhdar-Ghazal F; De Preval C
    Immunology; 1996 Mar; 87(3):414-20. PubMed ID: 8778027
    [TBL] [Abstract][Full Text] [Related]  

  • 66. T cell receptor gene segment utilization by HLA-DR1-alloreactive T cell clones.
    Geiger MJ; Gorski J; Eckels DD
    J Immunol; 1991 Oct; 147(7):2082-7. PubMed ID: 1833450
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Defensins are dominant HLA-DR-associated self-peptides from CD34(-) peripheral blood mononuclear cells of different tumor patients (plasmacytoma, chronic myeloid leukemia).
    Halder TM; Blüggel M; Heinzel S; Pawelec G; Meyer HE; Kalbacher H
    Blood; 2000 May; 95(9):2890-6. PubMed ID: 10779436
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation.
    Hurley CK; Steiner N; Wagner A; Geiger MJ; Eckels DD; Rosen-Bronson S
    J Immunol; 1993 Feb; 150(4):1314-24. PubMed ID: 8381833
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
    Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
    J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
    Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
    Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO; LaVaute T; Pinet V; Jaraquemada D
    J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MHC class II binding of peptides derived from HLA-DR 1.
    Harris PE; Liu Z; Suciu-Foca N
    J Immunol; 1992 Apr; 148(7):2169-74. PubMed ID: 1545124
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
    Denkberg G; Lev A; Eisenbach L; Benhar I; Reiter Y
    J Immunol; 2003 Sep; 171(5):2197-207. PubMed ID: 12928363
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
    Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
    Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Allele-specific variation in the degeneracy of major histocompatibility complex (MHC) restriction.
    Carmichael P; Copier J; So A; Lechler R
    Hum Immunol; 1997 Apr; 54(1):21-9. PubMed ID: 9154454
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
    Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
    Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Activation of a myelin basic protein-specific human T cell clone by antigen-presenting cells from rhesus monkeys.
    Meinl E; t Hart BA; Bontrop RE; Hoch RM; Iglesias A; de Waal Malefyt R; Fickenscher H; Müller-Fleckenstein I; Fleckenstein B; Wekerle H
    Int Immunol; 1995 Sep; 7(9):1489-95. PubMed ID: 7495756
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments.
    Held G; Matsuo M; Epel M; Gnjatic S; Ritter G; Lee SY; Tai TY; Cohen CJ; Old LJ; Pfreundschuh M; Reiter Y; Hoogenboom HR; Renner C
    Eur J Immunol; 2004 Oct; 34(10):2919-29. PubMed ID: 15368308
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets.
    Kropshofer H; Bohlinger I; Max H; Kalbacher H
    Biochemistry; 1991 Sep; 30(38):9177-87. PubMed ID: 1892827
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessing vaccine potency using TCRmimic antibodies.
    Neethling FA; Ramakrishna V; Keler T; Buchli R; Woodburn T; Weidanz JA
    Vaccine; 2008 Jun; 26(25):3092-102. PubMed ID: 18353510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.